The HADHSC Gene Encoding Short-Chain l-3-Hydroxyacyl-CoA Dehydrogenase (SCHAD) and Type 2 Diabetes Susceptibility

The short-chain l-3-hydroxyacyl-CoA dehydrogenase (SCHAD) protein is involved in the penultimate step of mitochondrial fatty acid oxidation. Previously, it has been shown that mutations in the corresponding gene (HADHSC) are associated with hyperinsulinism in infancy. The presumed function of the SCHAD enzyme in glucose-stimulated insulin secretion led us to the hypothesis that common variants in HADHSC on chromosome 4q22-26 might be associated with development of type 2 diabetes. In this study, we have performed a large-scale association study in four different cohorts from the Netherlands and Denmark (n = 7,365). Direct sequencing of HADHSC cDNA and databank analysis identified four tagging single nucleotide polymorphisms (SNPs) including one missense variant (P86L). Neither the SNPs nor haplotypes investigated were associated with the disease, enzyme function, or any relevant quantitative measure (all P > 0.1). The present study provides no evidence that the specific HADHSC variants or haplotypes examined do influence susceptibility to develop type 2 diabetes. We conclude that it is unlikely that variation in HADHSC plays a major role in the pathogenesis of type 2 diabetes in the examined cohorts.

[1]  H. Valkenburg,et al.  Prevalence and Determinants of Glucose Intolerance in a Dutch Caucasian Population: The Hoorn Study , 1995, Diabetes Care.

[2]  M. Bennett,et al.  Mitochondrial Short-Chain L-3-Hydroxyacl-Coenzyme A Dehydrogenase Deficiency: A New Defect of Fatty Acid Oxidation , 1996, Pediatric Research.

[3]  Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus , 2000, Diabetologia.

[4]  M. Schroll,et al.  Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60‐year‐old Danes , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[5]  P. Clayton,et al.  Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. , 2001, The Journal of clinical investigation.

[6]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[7]  G. Velho,et al.  Sulfonylurea receptor -1 (SUR1): genetic and metabolic evidences for a role in the susceptibility to type 2 diabetes mellitus. , 2002, Diabetes & metabolism.

[8]  L. Bouter,et al.  Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. , 2002, Diabetes care.

[9]  J. Dekker,et al.  Variations in insulin secretion in carriers of the E23K variant in the KIR6.2 subunit of the ATP-sensitive K(+) channel in the beta-cell. , 2002, Diabetes.

[10]  N. Westerhof,et al.  Arterial Stiffness Increases With Deteriorating Glucose Tolerance Status: The Hoorn Study , 2003, Circulation.

[11]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[12]  T. Jørgensen,et al.  Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. , 2003, Diabetes care.

[13]  D. Rakheja,et al.  Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. , 2003, American journal of physiology. Endocrinology and metabolism.

[14]  Charlotte Glümer,et al.  A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1) , 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[15]  M. McCarthy,et al.  Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. , 2003, Diabetes.

[16]  A. Butte,et al.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Daly,et al.  Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. , 2004, Diabetes.

[18]  G. Nijpels,et al.  Mitochondrial diabetes: molecular mechanisms and clinical presentation. , 2004, Diabetes.

[19]  R. Wanders,et al.  Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. , 2004, Diabetes.

[20]  Mark I McCarthy,et al.  Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification. , 2004, Human molecular genetics.

[21]  B. Lowell,et al.  Mitochondrial Dysfunction and Type 2 Diabetes , 2005, Science.